TNNT2 and myocardial infarction: Our study shows that adding hs-cTnT to the CHA2DS2-VASc score substantially improves risk stratification for adverse cardiovascular outcomes, including stroke, myocardial infarction, and all-cause mortality, particularly within this intermediate-risk population.